Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications

Acta Biomaterialia

Volumn 10, Issue 4, 2014, Pages 1588-1600

  Liang, Yingkai ^a   Kiick, Kristi L ^a,b  

^a UNIVERSITY OF DELAWARE   (United States)

^b University of Delaware   (United States)

Author keywords

Drug delivery; Heparin; Hydrogels; Nanoparticles; Tissue engineering

Indexed keywords

BIOMATERIALS; CONTROLLED DRUG DELIVERY; HYDROGELS; POLYSACCHARIDES; TARGETED DRUG DELIVERY; TISSUE; TISSUE ENGINEERING;

ANTIANGIOGENIC; ANTICOAGULANT ACTIVITIES; APOPTOTIC EFFECTS; BIOLOGICAL PROCESS; DRUG DELIVERY APPLICATIONS; FUNCTIONALIZED; GROWTH FACTOR; POLYMERIC BIOMATERIALS; PROPERTY; TISSUES ENGINEERINGS;

NANOPARTICLES;

AMIDE; BIOMATERIAL; GLUTATHIONE; HEPARIN; NANOPARTICLE; POLOXAMER; POLYELECTROLYTE; POLYMER; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADDITION REACTION; CANCER THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CROSS LINKING; DRUG DELIVERY SYSTEM; HEPARIN BASED HYDROGEL; HUMAN; HYDROGEL; MATERIAL COATING; MICHAEL ADDITION; PRIORITY JOURNAL; REVIEW; STIMULUS RESPONSE; SYNTHESIS; TISSUE ENGINEERING;

DRUG DELIVERY; HEPARIN; HYDROGELS; NANOPARTICLES; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HEPARIN; HUMANS; HYDROGELS; NANOPARTICLES; POLYMERS; TISSUE ENGINEERING;

EID: 84896394738     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.07.031     Document Type: Review

References (130)

1. I. Capila, and R.J. Linhardt Heparin-protein interactions Angew Chem Int Ed 41 2002 391 412
2. R.J. Linhardt, and S. Claude Hudson award address in carbohydrate chemistry. Heparin: Structure and activity J Med Chem 46 2003 2551 2564
3. D.L. Rabenstein Heparin and heparan sulfate: Structure and function Nat Prod Rep 19 2002 312 331
4. D. Gospodarowicz, and J. Cheng Heparin protects basic and acidic FGF from inactivation J Cell Physiol 128 1986 475 484
5. P.M. Kharkar, K.L. Kiick, and A.M. Kloxin Designing degradable hydrogels for orthogonal control of cell microenvironments Chem Soc Rev 42 2013 7335 7372
6. M.D. Freedman Pharmacodynamics, clinical indications, and adverse effects of heparin J Clin Pharmacol 32 1992 584 596
7. Y.M. Xu, S. Masuko, M. Takieddin, H.M. Xu, R.P. Liu, and J. Jing et al. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins Science 334 2011 498 501
8. K. Norrby, and P. Ostergaard Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight than by high-molecular-weight heparin Int J Microcirc 16 1996 8 15
9. R. Sasisekharan, Z. Shriver, G. Venkataraman, and U. Narayanasami Roles of heparan-sulphate glycosaminoglycans in cancer Nat Rev Cancer 2 2002 521 528
10. R.J. Linhardt Heparin-induced cancer cell death Chem Biol 11 2004 420 422
11. K.J. Cho, H.T. Moon, G.E. Park, O.C. Jeon, Y. Byun, and Y.K. Lee Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth Bioconjugate Chem 19 2008 1346 1351
12. J.W. Park, O.C. Jeon, S.K. Kim, T.A. Al-Hilal, S.J. Jin, and H.T. Moon et al. High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives J Controlled Release 148 2010 317 326
13. J.H. Lee, H. Lee, Y.K. Joung, K.H. Jung, J.H. Choi, and D.H. Lee et al. The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-beta/Smad signaling pathway Biomaterials 32 2011 1438 1445
14. K.L. Christman, V. Vazquez-Dorbatt, E. Schopf, C.M. Kolodziej, R.C. Li, and R.M. Broyer et al. Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer J Am Chem Soc 130 2008 16585 16591
15. C.M. Kolodziej, S.H. Kim, R.M. Broyer, S.S. Saxer, C.G. Decker, and H.D. Maynard Combination of integrin-binding peptide and growth factor promotes cell adhesion on electron-beam-fabricated patterns J Am Chem Soc 134 2012 247 255
16. T.H. Nguyen, S.-H. Kim, C.G. Decker, D.Y. Wong, J.A. Loo, and H.D. Maynard A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor Nat Chem 5 2013 221 227
17. N. Sangaj, P. Kyriakakis, D. Yang, C.W. Chang, G. Arya, and S. Varghese Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells Biomacromolecules 11 2010 3294 3300
18. R. Mammadov, B. Mammadov, S. Toksoz, B. Aydin, R. Yagci, and A.B. Tekinay et al. Heparin mimetic peptide nanofibers promote angiogenesis Biomacromolecules 12 2011 3508 3519
19. R. Mammadov, B. Mammadov, M.O. Guler, and A.B. Tekinay Growth factor binding on heparin mimetic peptide nanofibers Biomacromolecules 13 2012 3311 3319
20. M. Presta, D. Leali, H. Stabile, R. Ronca, M. Camozzi, and L. Coco et al. Heparin derivatives as angiogenesis inhibitors Curr Pharm Design 9 2003 553 566
21. L. García-Fernández, M.R. Aguilar, M.M. Fernández, R.M. Lozano, G. Giménez, and J.S. Román Antimitogenic polymer drugs based on AMPS: Monomer distribution-bioactivity relationship of water-soluble macromolecules Biomacromolecules 11 2010 626 634
22. L. García-Fernández, S. Halstenberg, R.E. Unger, M.R. Aguilar, C.J. Kirkpatrick, and J. San Román Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture Biomaterials 31 2010 7863 7872
23. A.D. Baldwin, K.G. Robinson, J.L. Militar, C.D. Derby, K.L. Kiick, and R.E. Akins In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release J Biomed Mater Res A 100A 2012 2106 2118
24. M. Fujita, M. Ishihara, M. Simizu, K. Obara, T. Ishizuka, and Y. Saito et al. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel Biomaterials 25 2004 699 706
25. S.T.M. Nillesen, P.J. Geutjes, R. Wismans, J. Schalkwijk, W.F. Daamen, and T.H. van Kuppevelt Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF Biomaterials 28 2007 1123 1131
26. Y.L. Li, J. Rodrigues, and H. Tomas Injectable and biodegradable hydrogels: Gelation, biodegradation and biomedical applications Chem Soc Rev 41 2012 2193 2221
27. G. Rohman, S.C. Baker, J. Southgate, and N.R. Cameron Heparin functionalisation of porous PLGA scaffolds for controlled, biologically relevant delivery of growth factors for soft tissue engineering J Mater Chem 19 2009 9265 9273
28. G.A. Hudalla, J.T. Koepsel, and W.L. Murphy Surfaces that sequester serum-borne heparin amplify growth factor activity Adv Mater 23 2011 5415 5418
29. J. Li, F. Lin, L.D. Li, J. Li, and S. Liu Surface engineering of poly(ethylene terephthalate) for durable hemocompatibility via a surface interpenetrating network technique Macromol Chem Phys 213 2012 2120 2129
30. J.A. Hubbell, and A. Chilkoti Nanomaterials for drug delivery Science 337 2012 303 305
31. M.M. Kemp, and R.J. Linhardt Heparin-based nanoparticles Wires Nanomed Nanobiotechnol 2 2010 77 87
32. Y.I. Chung, G. Tae, and S.H. Yuk A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors Biomaterials 27 2006 2621 2626
33. H.P. Tan, Q. Shen, X.J. Jia, Z.P. Yuan, and D.S. Xiong Injectable nanohybrid scaffold for biopharmaceuticals delivery and soft tissue engineering Macromol Rapid Commun 33 2012 2015 2022
34. X. Xu, A.K. Jha, R.L. Duncan, and X.Q. Jia Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2 Acta Biomater 7 2011 3050 3059
35. D. Peer, J.M. Karp, S. Hong, O.C. FaroKHzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 2 2007 751 760
36. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: An emerging treatment modality for cancer Nat Rev Drug Discov 7 2008 771 782
37. E.A. Appel, J. del Barrio, X.J. Loh, and O.A. Scherman Supramolecular polymeric hydrogels Chem Soc Rev 41 2012 6195 6214
38. M. Guvendiren, H.D. Lu, and J.A. Burdick Shear-thinning hydrogels for biomedical applications Soft Matter 8 2012 260 272
39. K.L. Kiick Peptide- and protein-mediated assembly of heparinized hydrogels Soft Matter 4 2008 29 37
40. B.L. Seal, and A. Panitch Physical polymer matrices based on affinity interactions between peptides and polysaccharides Biomacromolecules 4 2003 1572 1582
41. B.L. Seal, and A. Panitch Viscoelastic behavior of environmentally sensitive biomimetic polymer matrices Macromolecules 39 2006 2268 2274
42. B.L. Seal, and A. Panitch Physical matrices stabilized by enzymatically sensitive covalent crosslinks Acta Biomater 2 2006 241 251
43. K.J. Jeong, and A. Panitch Interplay between covalent and physical interactions within environment sensitive hydrogels Biomacromolecules 10 2009 1090 1099
44. N. Yamaguchi, and K.L. Kiick Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels Biomacromolecules 6 2005 1921 1930
45. N. Yamaguchi, B.S. Chae, L. Zhang, K.L. Kiick, and E.M. Furst Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels Biomacromolecules 6 2005 1931 1940
46. L. Zhang, E.M. Furst, and K.L. Kiick Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions J Controlled Release 114 2006 130 142
47. H.P. Tan, Q.X. Zhou, H.F. Qi, D. Zhu, X.X. Ma, and D.S. Xiong Heparin interacting protein mediated assembly of nano-fibrous hydrogel scaffolds for guided stem cell differentiation Macromol Biosci 12 2012 621 627
48. R. Wieduwild, M. Tsurkan, K. Chwalek, P. Murawala, M. Nowak, and U. Freudenberg et al. Minimal peptide motif for non-covalent peptide-heparin hydrogels J Am Chem Soc 135 2013 2919 2922
49. S.Y. Hong, J.E. Oh, and K.-H. Lee Effect of d-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide Biochem Pharmacol 58 1999 1775 1780
50. N. Yamaguchi, L. Zhang, B.S. Chae, C.S. Palla, E.M. Furst, and K.L. Kiick Growth factor mediated assembly of cell receptor-responsive hydrogels J Am Chem Soc 129 2007 3040 3041
51. S.H. Kim, and K.L. Kiick Cell-mediated delivery and targeted erosion of vascular endothelial growth factor-crosslinked hydrogels Macromol Rapid Commun 31 2010 1231 1240
52. T. Vermonden, R. Censi, and W.E. Hennink Hydrogels for protein delivery Chem Rev 112 2012 2853 2888
53. D.S.W. Benoit, and K.S. Anseth Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation Acta Biomater 1 2005 461 470
54. D.S.W. Benoit, A.R. Durney, and K.S. Anseth The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation Biomaterials 28 2007 66 77
55. A. Nilasaroya, L.A. Poole-Warren, J.M. Whitelock, and P.J. Martens Structural and functional characterisation of poly(vinyl alcohol) and heparin hydrogels Biomaterials 29 2008 4658 4664
56. O. Jeon, C. Powell, L.D. Solorio, M.D. Krebs, and E. Alsberg Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels J Controlled Release 154 2011 258 266
57. O. Oliviero, M. Ventre, and P.A. Netti Functional porous hydrogels to study angiogenesis under the effect of controlled release of vascular endothelial growth factor Acta Biomater 8 2012 3294 3301
58. T. Nie, A. Baldwin, N. Yamaguchi, and K.L. Kiick Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems J Controlled Release 122 2007 287 296
59. T. Nie, R.E. Akins, and K.L. Kiick Production of heparin-containing hydrogels for modulating cell responses Acta Biomater 5 2009 865 875
60. K.G. Robinson, T. Nie, A.D. Baldwin, E.C. Yang, K.L. Kiick, and R.E. Akins Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells J Biomed Mater Res A 100A 2012 1356 1367
61. G. Tae, Y.J. Kim, W.I. Choi, M. Kim, P.S. Stayton, and A.S. Hoffman Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules Biomacromolecules 8 2007 1979 1986
62. W. Il Choi, M. Kim, G. Tae, and Y.H. Kim Sustained release of human growth hormone from heparin-based hydrogel Biomacromolecules 9 2008 1698 1704
63. M. Kim, J.Y. Lee, C.N. Jones, A. Revzin, and G. Tae Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes Biomaterials 31 2010 3596 3603
64. M. Kim, S.E. Kim, S.S. Kang, Y.H. Kim, and G. Tae The use of de-differentiated chondrocytes delivered by a heparin-based hydrogel to regenerate cartilage in partial-thickness defects Biomaterials 32 2011 7883 7896
65. S.S. Cai, Y.C. Liu, X.Z. Shu, and G.D. Prestwich Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor Biomaterials 26 2005 6054 6067
66. D.B. Pike, S.S. Cai, K.R. Pomraning, M.A. Firpo, R.J. Fisher, and X.Z. Shu et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF Biomaterials 27 2006 5242 5251
67. R. Elia, P.W. Fuegy, A. VanDelden, M.A. Firpo, G.D. Prestwich, and R.A. Peattie Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels Biomaterials 31 2010 4630 4638
68. U. Freudenberg, A. Hermann, P.B. Welzel, K. Stirl, S.C. Schwarz, and M. Grimmer et al. A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases Biomaterials 30 2009 5049 5060
69. A. Zieris, S. Prokoph, K.R. Levental, P.B. Welzel, M. Grimmer, and U. Freudenberg et al. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis Biomaterials 31 2010 7985 7994
70. A. Zieris, K. Chwalek, S. Prokoph, K.R. Levental, P.B. Welzel, and U. Freudenberg et al. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels J Controlled Release 156 2011 28 36
71. T.P. Richardson, M.C. Peters, A.B. Ennett, and D.J. Mooney Polymeric system for dual growth factor delivery Nat Biotechnol 19 2001 1029 1034
72. L. Baumann, S. Prokoph, C. Gabriel, U. Freudenberg, C. Werner, and A.G. Beck-Sickinger A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro J Controlled Release 162 2012 68 75
73. S. Prokoph, E. Chavakis, K.R. Levental, A. Zieris, U. Freudenberg, and S. Dimmeler et al. Sustained delivery of SDF-1 alpha from heparin-based hydrogels to attract circulating pro-angiogenic cells Biomaterials 33 2012 4792 4800
74. P.B. Welzel, M. Grimmer, C. Renneberg, L. Naujox, S. Zschoche, and U. Freudenberg et al. Macroporous starPEG-heparin cryogels Biomacromolecules 13 2012 2349 2358
75. R. Jin, L.S.M. Teixeira, P.J. Dijkstra, C.A. van Blitterswijk, M. Karperien, and J. Feijen Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels J Controlled Release 152 2011 186 195
76. Y.K. Joung, S.S. You, K.M. Park, D.H. Go, and K.D. Park In situ forming, metal-adhesive heparin hydrogel surfaces for blood-compatible coating Colloid Surface B 99 2012 102 107
77. S. Ernst, R. Langer, C.L. Cooney, and R. Sasisekharan Enzymatic degradation of glycosaminoglycans Crit Rev Biochem Mol 30 1995 387 444
78. A. Nilasaroya, P.J. Martens, and J.M. Whitelock Enzymatic degradation of heparin-modified hydrogels and its effect on bioactivity Biomaterials 33 2012 5534 5540
79. M.P. Lutolf, J.L. Lauer-Fields, H.G. Schmoekel, A.T. Metters, F.E. Weber, and G.B. Fields et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics Proc Natl Acad Sci USA 100 2003 5413 5418
80. T.P. Kraehenbuehl, L.S. Ferreira, P. Zammaretti, J.A. Hubbell, and R. Langer Cell-responsive hydrogel for encapsulation of vascular cells Biomaterials 30 2009 4318 4324
81. J. Patterson, and J.A. Hubbell Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2 Biomaterials 31 2010 7836 7845
82. B.D. Fairbanks, M.P. Schwartz, A.E. Halevi, C.R. Nuttelman, C.N. Bowman, and K.S. Anseth A versatile synthetic extracellular matrix mimic via thiol-norbornene photopolymerization Adv Mater 21 2009 5005 5010
83. S.B. Anderson, C.C. Lin, D.V. Kuntzler, and K.S. Anseth The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels Biomaterials 32 2011 3564 3574
84. J.A. Burdick, and W.L. Murphy Moving from static to dynamic complexity in hydrogel design Nat Commun 3 2012 1269
85. M.V. Tsurkan, K.R. Levental, U. Freudenberg, and C. Werner Enzymatically degradable heparin-polyethylene glycol gels with controlled mechanical properties Chem Commun 46 2010 1141 1143
86. M.V. Tsurkan, K. Chwalek, K.R. Levental, U. Freudenberg, and C. Werner Modular starPEG-heparin gels with bifunctional peptide linkers Macromol Rapid Commun 31 2010 1529 1533
87. K. Chwalek, K.R. Levental, M.V. Tsurkan, A. Zieris, U. Freudenberg, and C. Werner Two-tier hydrogel degradation to boost endothelial cell morphogenesis Biomaterials 32 2011 9649 9657
88. F. Meng, W.E. Hennink, and Z. Zhong Reduction-sensitive polymers and bioconjugates for biomedical applications Biomaterials 30 2009 2180 2198
89. D. Roy, J.N. Cambre, and B.S. Sumerlin Future perspectives and recent advances in stimuli-responsive materials Prog Polym Sci 35 2010 278 301
90. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, and Z. Zhong Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J Controlled Release 152 2011 2 12
91. S.Y. Choh, D. Cross, and C. Wang Facile synthesis and characterization of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation Biomacromolecules 12 2011 1126 1136
92. E. Lallana, and N. Tirelli Oxidation-responsive polymers: Which groups to use, how to make them, what to expect from them (biomedical applications) Macromol Chem Phys 214 2013 143 158
93. A.D. Baldwin, and K.L. Kiick Tunable degradation of maleimide-thiol adducts in reducing environments Bioconjugate Chem 22 2011 1946 1953
94. A.D. Baldwin, and K.L. Kiick Reversible maleimide-thiol adducts yield glutathione-sensitive poly(ethylene glycol)-heparin hydrogels Polym Chem 4 2013 133 143
95. C.C. Yeh, M.F. Hou, S.H. Wu, S.M. Tsai, S.K. Lin, and L.A. Hou et al. A study of glutathione status in the blood and tissues of patients with breast cancer Cell Biochem Funct 24 2006 555 559
96. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
97. T. Lammers, W.E. Hennink, and G. Storm Tumour-targeted nanomedicines: Principles and practice Brit J Cancer 99 2008 392 397
98. W.W. Gao, J.M. Chan, and O.C. Farokhzad PH-responsive nanoparticles for drug delivery Mol Pharmaceutics 7 2010 1913 1920
99. J.H. Gao, H.W. Gu, and B. Xu Multifunctional magnetic nanoparticles: Design, synthesis, and biomedical applications Acc Chem Res 42 2009 1097 1107
100. C.J. Murphy, A.M. Gole, J.W. Stone, P.N. Sisco, A.M. Alkilany, and E.C. Goldsmith et al. Gold nanoparticles in biology: Beyond toxicity to cellular imaging Acc Chem Res 41 2008 1721 1730
101. K. Raemdonck, J. Demeester, and S. De Smedt Advanced nanogel engineering for drug delivery Soft Matter 5 2009 707 715
102. M.H. Smith, and L.A. Lyon Multifunctional nanogels for siRNA delivery Acc Chem Res 45 2012 985 993
103. S.H. Yuk, K.S. Oh, S.H. Cho, B.S. Lee, S.Y. Kim, and B.K. Kwak et al. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging Biomacromolecules 12 2011 2335 2343
104. J.H. Lee, M.J. Jung, Y.H. Hwang, Y.J. Lee, S. Lee, and D.Y. Lee et al. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs Biomaterials 33 2012 4861 4871
105. K. Lee, H. Lee, K.H. Bae, and T.G. Park Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells Biomaterials 31 2010 6530 6536
106. K.E. Sapsford, W.R. Algar, L. Berti, K.B. Gemmill, B.J. Casey, and E. Oh et al. Functionalizing nanoparticles with biological molecules: Developing chemistries that facilitate nanotechnology Chem Rev 113 2013 1904 2074
107. Y.I. Chung, S.K. Kim, Y.K. Lee, S.J. Park, K.O. Cho, and S.H. Yuk et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex J Controlled Release 143 2010 282 289
108. S. Boddohi, N. Moore, P.A. Johnson, and M.J. Kipper Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan Biomacromolecules 10 2009 1402 1409
109. S. Boddohi, J. Almodovar, H. Zhang, P.A. Johnson, and M.J. Kipper Layer-by-layer assembly of polysaccharide-based nanostructured surfaces containing polyelectrolyte complex nanoparticles Colloid Surf B 77 2010 60 68
110. F.Z. Volpato, J. Almodovar, K. Erickson, K.C. Popat, C. Migliaresi, and M.J. Kipper Preservation of FGF-2 bioactivity using heparin-based nanoparticles, and their delivery from electrospun chitosan fibers Acta Biomater 8 2012 1551 1559
111. D.W. Tang, S.H. Yu, Y.C. Ho, F.L. Mi, P.L. Kuo, and H.W. Sung Heparinized chitosan/poly(gamma-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin Biomaterials 31 2010 9320 9332
112. F. Reyes-Ortega, G. Rodriguez, M.R. Aguilar, M. Lord, J. Whitelock, and M.H. Stenzel et al. Encapsulation of low molecular weight heparin (bemiparin) into polymeric nanoparticles obtained from cationic block copolymers: Properties and cell activity J Mater Chem B 1 2013 850 860
113. Y. Zhao, M.S. Lord, and M.H. Stenzel A polyion complex micelle with heparin for growth factor delivery and uptake into cells J Mater Chem B 1 2013 1635 1643
114. B. Glimelius, C. Busch, and M. Höök Binding of heparin on the surface of cultured human endothelial cells Thromb Res 12 1978 773 782
115. Y. Shing, J. Folkman, R. Sullivan, C. Butterfield, J. Murray, and M. Klagsbrun Heparin affinity - purification of a tumor-derived capillary endothelial cell-growth factor Science 223 1984 1296 1299
116. Y.I. Chung, J.C. Kim, Y.H. Kim, G. Tae, S.Y. Lee, and K. Kim et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting J Controlled Release 143 2010 374 382
117. J.H. Choi, J.Y. Jang, Y.K. Joung, M.H. Kwon, and K.D. Park Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A J Controlled Release 147 2010 420 427
118. Y.K. Joung, J.Y. Jang, J.H. Choi, D.K. Han, and K.D. Park Heparin-conjugated pluronic nanogels as muiti-drug nanocarriers for combination chemotherapy Mol Pharmaceutics 10 2013 685 693
119. K.H. Bae, H. Mok, and T.G. Park Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death Biomaterials 29 2008 3376 3383
120. Y. Wang, D.C. Xin, K.J. Liu, M.Q. Zhu, and J.N. Xiang Heparin-paclitaxel conjugates as drug delivery system: Synthesis, self-assembly property, drug release, and antitumor activity Bioconjugate Chem 20 2009 2214 2221
121. Y. Wang, Y.Q. Wang, J.N. Xiang, and K.T. Yao Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles Biomacromolecules 11 2010 3531 3538
122. L. Li, K.M. Huh, Y.K. Lee, and S.Y. Kim Biofunctional self-assembled nanoparticles of folate-PEG-heparin/PBLA copolymers for targeted delivery of doxorubicin J Mater Chem 21 2011 15288 15297
123. W.C. She, N. Li, K. Luo, C.H. Guo, G. Wang, and Y.Y. Geng et al. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy Biomaterials 34 2013 2252 2264
124. J. Hasan, S.D. Shnyder, A.R. Clamp, A.T. McGown, R. Bicknell, and M. Presta et al. Heparin octasaccharides inhibit angiogenesis in vivo Clin Cancer Res 11 2005 8172 8179
125. N. Hostettler, A. Naggi, G. Torri, R. Ishai-Michaeli, B. Casu, and I. Vlodavsky et al. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins FASEB J 21 2007 3562 3572
126. D.Y. Lee, S.W. Lee, S.K. Kim, M. Lee, H.W. Chang, and H.T. Moon et al. Antiangiogenic activity of orally absorbable heparin derivative in different types of cancer cells Pharm Res 26 2009 2667 2676
127. A.M. Kloxin, A.M. Kasko, C.N. Salinas, and K.S. Anseth Photodegradable hydrogels for dynamic tuning of physical and chemical properties Science 324 2009 59 63
128. J.N. Brantley, K.M. Wiggins, and C.W. Bielawski Unclicking the click: Mechanically facilitated 1,3-dipolar cycloreversions Science 333 2011 1606 1609
129. K.M. Schultz, A.D. Baldwin, K.L. Kiick, and E.M. Furst Rapid rheological screening to identify conditions of biomaterial hydrogelation Soft Matter 5 2009 740 742
130. K.M. Schultz, and E.M. Furst Microrheology of biomaterial hydrogelators Soft Matter 8 2012 6198 6205